Pantoprazole Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 83634-751

2 FDA label images from Avenacy, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 83634-751). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avenacy, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Pan0b 0001 01)

Figure (Pan0b 0001 01)
Chemical structure of pantoprazole sodium showing its molecular arrangement, including heterocyclic rings, methoxy groups, sulfinyl group, and a sodium ion.*
FDA Label Image

Package Label – Principal Display Panel – Vial Label (Pan0b 0001 02)

Package Label – Principal Display Panel – Vial Label (Pan0b 0001 02)
Pantoprazole Sodium for Injection 40 mg per vial single-dose vial label. The sterile lyophilized powder is for intravenous infusion only, containing pantoprazole sodium equivalent to 40 mg pantoprazole. The label includes storage instructions and identifies Avenacy, LLC as the manufacturer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.